ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images/10738/ihc_cell_selected_60x60.jpg) | ![](/images/10738/26586_B_7_1_rna_selected_60x60.jpg) | Expressed in all |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64637/143728_A_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/16394/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/16394/36382_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images/42014/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42014/98164_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28567/62983_B_8_6_rna_selected_60x60.jpg) | Mixed |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | ![](/images/6279/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/6279/17967_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADAP1 | ArfGAP with dual PH domains 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/12049/30046_B_8_6_rna_selected_60x60.jpg) | Mixed |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/56157/121410_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
ADARB1 | Adenosine deaminase, RNA-specific, B1 | Enzymes Plasma proteins
| ![](/images/18277/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/18277/42056_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
ADAT1 | Adenosine deaminase, tRNA-specific 1 | Enzymes
| ![](/images/40713/ihc_selected_60x60.jpg) | | ![](/images/40713/ihc_cell_selected_60x60.jpg) | ![](/images/40713/89631_A_3_1_rna_selected_60x60.jpg) | Expressed in all |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18217/41186_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
ADCK4 | AarF domain containing kinase 4 | Disease related genes Enzymes Potential drug targets
| | ![](/images/27229/if_selected_60x60.jpg) | ![](/images/27229/ihc_cell_selected_60x60.jpg) | ![](/images/27277/61284_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | ![](/images/28679/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25692/61979_B_9_7_rna_selected_60x60.jpg) | Expressed in all |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38015/84094_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted membrane proteins
| ![](/images/10223/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/10223/25240_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
ADD1 | Adducin 1 (alpha) | Cytoskeleton related proteins Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/35873/114845_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
ADD3 | Adducin 3 (gamma) | Cytoskeleton related proteins
| | | | ![](/images/35696/124479_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44578/123080_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted secreted proteins
| ![](/images/35403/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/35403/69882_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ADIRF | Adipogenesis regulatory factor | Plasma proteins
| ![](/images/26810/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26810/57106_A_4_7_rna_selected_60x60.jpg) | Tissue enhanced |
ADK | Adenosine kinase | Disease related genes Enzymes FDA approved drug targets
| ![](/images/38409/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38391/80914_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
ADNP | Activity-dependent neuroprotector homeobox | Cancer-related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/6371/17484_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ADNP2 | ADNP homeobox 2 | Transcription factors
| ![](/images/7126/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/7126/18515_B_8_1_rna_selected_60x60.jpg) | Mixed |
ADO | 2-aminoethanethiol (cysteamine) dioxygenase | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40437/93489_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | ![](/images/43951/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/66478/148785_B_7_3_rna_selected_60x60.jpg) | Group enriched |
ADPRHL2 | ADP-ribosylhydrolase like 2 | Enzymes Predicted secreted proteins
| | | ![](/images/27104/ihc_cell_selected_60x60.jpg) | ![](/images/27141/58661_B_2_5_rna_selected_60x60.jpg) | Expressed in all |
ADPRM | ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent | Enzymes Predicted membrane proteins
| ![](/images/23820/ihc_selected_60x60.jpg) | ![](/images/23820/if_selected_60x60.jpg) | | ![](/images/23820/52348_B_3_3_rna_selected_60x60.jpg) | Expressed in all |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67972/149849_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins
| | ![](/images/48330/if_selected_60x60.jpg) | | ![](/images/37248/86035_A_9_6_rna_selected_60x60.jpg) | Expressed in all |
ADRM1 | Adhesion regulating molecule 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/42266/93667_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ADSL | Adenylosuccinate lyase | Disease related genes Enzymes Potential drug targets
| | | | ![](/images/19285/42511_B_2_5_rna_selected_60x60.jpg) | Expressed in all |
ADSS | Adenylosuccinate synthase | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/24400/52832_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
AEN | Apoptosis enhancing nuclease | | ![](/images/48599/ihc_selected_60x60.jpg) | | ![](/images/48599/ihc_cell_selected_60x60.jpg) | ![](/images/48599/120138_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
AFAP1 | Actin filament associated protein 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/15642/36001_A_3_8_rna_selected_60x60.jpg) | Mixed |
AFAP1L1 | Actin filament associated protein 1-like 1 | | | ![](/images/7329/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7329/19606_B_9_2_rna_selected_60x60.jpg) | Mixed |
AFAP1L2 | Actin filament associated protein 1-like 2 | | ![](/images/37843/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/37843/76927_B_5_6_rna_selected_60x60.jpg) | Tissue enhanced |
AFF3 | AF4/FMR2 family, member 3 | Cancer-related genes
| ![](/images/44512/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/44512/99012_B_9_7_rna_selected_60x60.jpg) | Mixed |
AFF4 | AF4/FMR2 family, member 4 | Cancer-related genes Disease related genes
| ![](/images/23690/ihc_selected_60x60.jpg) | | ![](/images/23690/ihc_cell_selected_60x60.jpg) | ![](/images/23690/51734_A_3_3_rna_selected_60x60.jpg) | Expressed in all |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/4480/13731_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
AFTPH | Aftiphilin | | ![](/images/34990/ihc_selected_60x60.jpg) | | | ![](/images/34990/71301_B_8_8_rna_selected_60x60.jpg) | Expressed in all |
AGA | Aspartylglucosaminidase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images/31415/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31415/71138_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | | ![](/images/23474/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/23474/50193_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
AGAP3 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12883/29391_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
AGFG1 | ArfGAP with FG repeats 1 | | ![](/images/8741/ihc_selected_60x60.jpg) | | | ![](/images/8741/23414_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
AGFG2 | ArfGAP with FG repeats 2 | | | ![](/images_static/na_center.gif) | ![](/images/19689/ihc_cell_selected_60x60.jpg) | ![](/images/19689/142527_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
AGK | Acylglycerol kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | ![](/images/20959/ihc_cell_selected_60x60.jpg) | ![](/images/53471/128546_A_1_5_rna_selected_60x60.jpg) | Expressed in all |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/28498/61637_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
AGO2 | Argonaute RISC catalytic component 2 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19309/44339_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
AGO4 | Argonaute RISC catalytic component 4 | | ![](/images/12179/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/12179/28985_B_8_1_rna_selected_60x60.jpg) | Expressed in all |